Vincent M Isabella

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

David Lubkowicz, Nicholas G Horvath, Michael J James, Pasquale Cantarella, Lauren Renaud, Christopher G Bergeron, Ron B Shmueli, Cami Anderson, Jian-Rong Gao, Caroline B Kurtz, Mylene Perreault, Mark R Charbonneau, Vincent M Isabella, David L Hava
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria. Molecular systems biology 18 (3) (2022)
Kristin J Adolfsen, Isolde Callihan, Catherine E Monahan, Per Jr Greisen, James Spoonamore, Munira Momin, Lauren E Fitch, Mary Joan Castillo, Lindong Weng, Lauren Renaud, Carl J Weile, Jay H Konieczka, Teodelinda Mirabella, Andres Abin-Fuentes, Adam G Lawrence, Vincent M Isabella
Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering. Nature communications 12 (1) (2021)
Caroline B Kurtz, Yves A Millet, Marja K Puurunen, Mylène Perreault, Mark R Charbonneau, Vincent M Isabella, Jonathan W Kotula, Eugene Antipov, Yossi Dagon, William S Denney, David A Wagner, Kip A West, Andrew J Degar, Aoife M Brennan, Paul F Miller
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science translational medicine 11 (475) (2020)

Vincent M Isabella.css-eqlu8i{font-size:small;padding-left:4px;}